Menu Close

Ana Santos Rutschman

Professor of Law, Villanova School of Law

Ana Santos Rutschman is a professor of law at Villanova University, where she teaches courses in health law, intellectual property, and regulation in the life sciences. She researches and writes on topics related to emerging health technologies, with a particular focus on vaccines and other forms of biotechnology. She has also published on topics related to e-health, global public health and artificial intelligence. She has spoken on these topics in conferences and panels around the world. In 2015-16, she consulted for the World Health Organization on matters related to the development of the Ebola and Zika vaccines. In 2017, she was named a Bio IP Scholar by the American Society of Law, Medicine & Ethics, and in 2018 she was named a Health Law Scholar by the same institution.


  • 2022–present
    Professor, Villanova University
  • 2018–2022
    Assistant Professor, Saint Louis University School of Law
  • 2016–2018
    Faculty Fellow in Health Law and Intellectual Property, DePaul University College of Law


  • 2016 
    Duke Law School, SJD
  • 2008 
    Duke Law School, LLM in Intellectual Property


  • 2022
    Vaccines as Technology, Cambridge University Press
  • 2021
    The Case Against Monetary Behavioral Incentives in the Context of COVID-19 Vaccination (with Timothy Wiemken), Harvard Public Health Review
  • 2021
    Property and Intellectual Property in Vaccine Markets, Texas A&M Property Law Journal
  • 2021
    Intellectual Property as a Determinant of Health, Vanderbilt Journal of Transnational Law
  • 2021
    Social Media Self-Regulation and the Rise of Vaccine Misinformation, University of Pennsylvannia Journal of Law and Innovation
  • 2021
    Vaccine Clinical Trials and Data Infrastructure, Utah Law Review
  • 2021
    Development of Vaccines for Influenza Disease: Opportunity Costs of the COVID-19 Pandemic (with Timothy Wiemken), Vaccine
  • 2021
    Is There a Cure for Vaccine Nationalism?, Current History
  • 2021
    The COVID-19 Vaccine Race: Intellectual Property, Collaboration(s), Nationalism and Misinformation, Washington University Journal of Law and Policy
  • 2020
    The Reemergence of Vaccine Nationalism, Georgetown Journal of International Affairs Online
  • 2020
    Regulatory Malfunctions in the Drug Patent Ecosystem , Emory Law Journal
  • 2020
    The Intellectual Property of Vaccines: Takeaways from Recent Infectious Disease Outbreaks, Michigan Law Review Online
  • 2020
    A Machine Learning Primer for Infection Prevention and Control (with Timothy Wiemken), American Journal of Infection Control
  • 2019
    On the Judicialization of Health, Washington University Global Studies Law Review
  • 2019
    The Vaccine Race in the 21st Century, Arizona Law Review
  • 2018
    IP Preparedness for Outbreak Diseases, UCLA Law Review
  • 2018
    Vaccine Licensure in the Public Interest: Lessons from the Development of the US Army Zika Vaccine, Yale Law Journal Forum
  • 2017
    The Priority Review Voucher Program at the FDA: From Neglected Tropical Diseases to the 21st Century Cures Act, Annals of Health Law


2017 Bio IP Scholar (American Society of Law, Medicine & Ethics); 2018 Health Law Scholar (American Society of Law, Medicine & Ethics); 2019 Manzo Scholar in Patent Law; 2019 Fellow (CIPPM/Jean Monnet Centre of Excellence for European Intellectual Property and Information Rights); 2022: 40 Under 40 Public Health Catalyst Award, Boston Congress on Public Health